Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Emmerling

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Neurological Research|September 25, 2003
Hippocampal nitric oxide upregulation precedes memory loss and A beta 1-40 accumulation after chronic brain hypoperfusion in ratsJ C de la Torre, B A Pappas, V Prevot, et al.
Biochemical and Biophysical Research Communications|April 20, 1999
High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's diseaseY M Kuo, M R Emmerling, H C Lampert, et al.
Biochemical and Biophysical Research Communications|February 19, 2000
Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasmaY M Kuo, T A Kokjohn, W Kalback, et al.
The Journal of Biological Chemistry|February 23, 1996
Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brainsY M Kuo, M R Emmerling, C Vigo-Pelfrey, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Cortical cholinergic denervation elicits vascular A beta depositionA E Roher, Y M Kuo, P E Potter, et al.
Molecular Neurobiology|August 1, 1994
PD 142676 (CI 1002), a novel anticholinesterase and muscarinic antagonistM R Emmerling, V E Gregor, R D Schwarz, et al.
The American Journal of Pathology|March 7, 2000
Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolismY M Kuo, T A Kokjohn, M D Watson, et al.
Neuroscience Letters|March 24, 2000
Cholinergic deafferentation of the rabbit cortex: a new animal model of Abeta depositionT G Beach, P E Potter, Y M Kuo, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
Benzenesulfonamide derivatives of 2-substituted 4H-3,1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r proteaseJ S Plummer, C Cai, S J Hays, et al.
Journal of Medicinal Chemistry|April 17, 1998
2-amino-4H-3,1-benzoxazin-4-ones as inhibitors of C1r serine proteaseS J Hays, B W Caprathe, J L Gilmore, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Neurological Research|September 25, 2003
Hippocampal nitric oxide upregulation precedes memory loss and A beta 1-40 accumulation after chronic brain hypoperfusion in ratsJ C de la Torre, B A Pappas, V Prevot, et al.
Biochemical and Biophysical Research Communications|April 20, 1999
High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's diseaseY M Kuo, M R Emmerling, H C Lampert, et al.
Biochemical and Biophysical Research Communications|February 19, 2000
Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasmaY M Kuo, T A Kokjohn, W Kalback, et al.
The Journal of Biological Chemistry|February 23, 1996
Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brainsY M Kuo, M R Emmerling, C Vigo-Pelfrey, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Cortical cholinergic denervation elicits vascular A beta depositionA E Roher, Y M Kuo, P E Potter, et al.
Molecular Neurobiology|August 1, 1994
PD 142676 (CI 1002), a novel anticholinesterase and muscarinic antagonistM R Emmerling, V E Gregor, R D Schwarz, et al.
The American Journal of Pathology|March 7, 2000
Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolismY M Kuo, T A Kokjohn, M D Watson, et al.
Neuroscience Letters|March 24, 2000
Cholinergic deafferentation of the rabbit cortex: a new animal model of Abeta depositionT G Beach, P E Potter, Y M Kuo, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
Benzenesulfonamide derivatives of 2-substituted 4H-3,1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r proteaseJ S Plummer, C Cai, S J Hays, et al.
Journal of Medicinal Chemistry|April 17, 1998
2-amino-4H-3,1-benzoxazin-4-ones as inhibitors of C1r serine proteaseS J Hays, B W Caprathe, J L Gilmore, et al.
Pageof 5